VM
ORKA

VHCP Management’s Oruka Therapeutics ORKA Stock Holding History

VHCP Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.32M Hold
2,141
– – 1.42% 16
2016
Q3 		$1.31M Hold
2,141
– – 1.29% 19
2016
Q2 		$1.34M Hold
2,141
– – 1.39% 16
2016
Q1 		$1.6M Hold
2,141
– – 1.39% 14
2015
Q4 		$2.15M Sell
2,141
-4,995
-70% -$5.66M 1.3% 13
2015
Q3 		$7.64M Hold
7,136
– – 1.96% 14
2015
Q2 		$12.4M Buy
+7,136
New +$9.38M 3.5% 9

Other funds holding ORKA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACP
Aveo Capital Partners Englewood, Colorado $601M AUM 5.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VHCP Management's ORKA Position: Q4 2016 in Review

VHCP Management held its Oruka Therapeutics (ORKA) position steady in Q4 2016 at 2,141 shares worth $1.32M. The position accounts for 1.42% of the portfolio, ranked #16.

VHCP Management first reported a position in ORKA in Q2 2015 and has held it in 7 quarters since. The position peaked at $12.4M in Q2 2015. 17 funds tracked by Wall St. Rank hold ORKA as of Q4 2016.

  • VHCP Management held 2,141 shares of Oruka Therapeutics worth $1.32M as of Q4 2016.
  • VHCP Management left its Oruka Therapeutics share count unchanged in Q4 2016.
  • Oruka Therapeutics made up 1.42% of VHCP Management's portfolio in Q4 2016, its #16 holding.
  • VHCP Management first reported a position in Oruka Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • VHCP Management's Oruka Therapeutics position peaked at $12.4M in Q2 2015.
  • 17 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.